Sepracor Inc. has announced that the Federal Trade Commission (FTC) has closed its investigation, under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act, of the license agreement that allows Eli Lilly and Company to exclusively develop and globally commercialize (R) – fluoxetine. (R)-Fluoxetine, a new chemical entity, is a modified form of an active ingredient found in Read more about (R)-Fluoxetine License Agreement To Become Effective[…]